TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19055806

Group type: EXPERIMENTAL
Intervention: Basic tailored intervention (three tailored letters over four months targeting psychosocial determinants of physical activity)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intervention plus (same as basic tailored intervention plus tailored information about physical activity opportunities in the specific environment, access to a forum and e-buddy system)
Number of subjects: 0
Study: 16119233

Group type: EXPERIMENTAL
Intervention: Berkner transform-based multiscale detector for genioglossus EMG reflex
Number of subjects: 0
Study: 12372663

Group type: EXPERIMENTAL
Intervention: 1 mg of nicotine administered by nasal spray
Number of subjects: 55
Study: 10411037

Group type: EXPERIMENTAL
Intervention: Sacral nerve stimulation (treatment group)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Delay group (control)
Number of subjects: 76
Study: 7475198

Group type: EXPERIMENTAL
Intervention: Nifedipine and Metoprolol (n = 34)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Nifedipine (n = 36)
Number of subjects: 70
Study: 2137717

Group type: EXPERIMENTAL
Intervention: Laser group
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50
Study: 7419336

Group type: COMPARATOR
Intervention: Total fasting (TF)
Number of subjects: 25

Group type: COMPARATOR
Intervention: 80 kcal-PSMF (17 g protein=2.6 g N)
Number of subjects: 25

Group type: COMPARATOR
Intervention: 180 kcal-PSMF (40 g protein=6.4 g N, 2 g fat)
Number of subjects: 25

Group type: COMPARATOR
Intervention: 80/180 kcal-PSMF (80 kcal for 1st and 2nd week, 180 kcal for 3rd and 4th week)
Number of subjects: 25
Study: 31759229

Group type: EXPERIMENTAL
Intervention: Dual-task intervention (recalling threat memory while performing a secondary task)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Recall only task (without the dual-task)
Number of subjects: 75

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 75
Study: 30285795

Group type: EXPERIMENTAL
Intervention: Thoracoscopic pulmonary vein ablation
Number of subjects: 21

Group type: COMPARATOR
Intervention: Catheter pulmonary vein ablation
Number of subjects: 21
Study: 27667330

Group type: EXPERIMENTAL
Intervention: Brief one‐to‐one education
Number of subjects: 321

Group type: COMPARATOR
Intervention: Standard antenatal care
Number of subjects: 321

Group type: EXPERIMENTAL
Intervention: If participants who attempted vaccination had received the vaccine
Number of subjects: 321
Study: 25271984

Group type: EXPERIMENTAL
Intervention: Laetiporus sulphureus (LS)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Trametes versicolor + Ganoderma lucidum (TV+GL)
Number of subjects: 61
Study: 21331065

Group type: EXPERIMENTAL
Intervention: Greater intake of saturated fat at 6 months
Number of subjects: 810

Group type: EXPERIMENTAL
Intervention: Greater intake of plant protein at 6 months
Number of subjects: 810
Study: 21084608

Group type: EXPERIMENTAL
Intervention: Developmental changes in effective connectivity underlying inhibitory control (antisaccade task)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reflexive responses (prosaccade task)
Number of subjects: 0
Study: 18684256

Group type: EXPERIMENTAL
Intervention: Ablation at the right midseptum
Number of subjects: 63

Group type: COMPARATOR
Intervention: Ablation at the Rt-IS or PCS
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Superior type tachycardia
Number of subjects: 63

Group type: COMPARATOR
Intervention: Inferior type tachycardia
Number of subjects: 63
Study: 15635208

Group type: EXPERIMENTAL
Intervention: Treatment (face immersion test)
Number of subjects: 5
Study: 12878742

Group type: EXPERIMENTAL
Intervention: EGF enemas (5 microg in 100 ml of inert carrier)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: EGF enemas
Number of subjects: 12
Study: 11045236

Group type: EXPERIMENTAL
Intervention: Misinformation items
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-misinformation items
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Individual difference measures
Number of subjects: 0
Study: 8803527

Group type: EXPERIMENTAL
Intervention: 76 mg disodium monofluorophosphate (MFP, equivalent to 10.0 mg F- ion)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 25 mg enteric-coated sodium fluoride (NaFor, equivalent of 11.3 mg F- ion)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 22.1 mg sodium fluoride injection solution (NaFiv, equivalent to 10.0 mg F- ion)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 13
Study: 1728720

Group type: EXPERIMENTAL
Intervention: Insulin treatment (25 U fast-acting insulin bolus followed by continuous infusion of 1 U/kg body weight for 1 hour)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (no specific treatment mentioned)
Number of subjects: 18
Study: 6690344

Group type: EXPERIMENTAL
Intervention: sorbinil (250 mg o.d.)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: sorbinil (5 mg/kg)
Number of subjects: 15
Study: 31805787

Group type: EXPERIMENTAL
Intervention: THRIVES intervention (patient global risk factor control report card, personalized phone text-messaging, educational video)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Control group (text messages, modest financial incentives)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: THRIVES intervention (for subgroup with baseline BP >140/90 mm Hg, n=168)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Control group (for subgroup with baseline BP >140/90 mm Hg, n=168)
Number of subjects: 400
Study: 30514364

Group type: EXPERIMENTAL
Intervention: Enriched flours alone
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Enriched flours with prebiotics
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Enriched flours coupled with antibiotic treatment
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Developmental Milestones Checklist II (DMC II) questionnaire
Number of subjects: 100
Study: 26431778

Group type: EXPERIMENTAL
Intervention: Programmed intermittent epidural bolus (PIEB)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Continuous epidural infusion (CEI)
Number of subjects: 104
Study: 26092771

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (imitated acupuncture procedure)
Number of subjects: 40
Study: 23156122

Group type: EXPERIMENTAL
Intervention: Nutrition counseling in the third trimester (education twice in the first month and once a month for the next 2 months)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Nutrition counseling in the third trimester
Number of subjects: 115

Group type: COMPARATOR
Intervention: Routine hospital advice (comparison group)
Number of subjects: 115
Study: 21082306

Group type: EXPERIMENTAL
Intervention: Low-dose chlorhexidine solution (CHX)
Number of subjects: 31

Group type: COMPARATOR
Intervention: No chlorhexidine solution (no CHX)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Invisalign treatment
Number of subjects: 31
Study: 19281091

Group type: EXPERIMENTAL
Intervention: Respimat Soft Mist Inhaler (SMI)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Hydrofluoroalkane (HFA)‐MDI
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Training
Number of subjects: 13
Study: 15852426

Group type: EXPERIMENTAL
Intervention: Laparoscopic Nissen fundoplication (LNF)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Proton-pump inhibitor (PPI) therapy
Number of subjects: 100
Study: 12769404

Group type: EXPERIMENTAL
Intervention: Topical diclofenac
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topical colchicine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topical retinoids
Number of subjects: 0
Study: 11783194

Group type: EXPERIMENTAL
Intervention: Jianruling (JRL) treatment
Number of subjects: 0
Study: 8709734

Group type: EXPERIMENTAL
Intervention: New programme of antenatal care (median 4 visits)
Number of subjects: 15994

Group type: EXPERIMENTAL
Intervention: New programme of antenatal care
Number of subjects: 15994

Group type: COMPARATOR
Intervention: Standard programme of antenatal care (median 6 visits)
Number of subjects: 15994

Group type: COMPARATOR
Intervention: Standard programme of antenatal care
Number of subjects: 15994
Study: 1869004

Group type: EXPERIMENTAL
Intervention: nalbuphine (0.1 mg/kg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: pethidine (0.8 mg/kg)
Number of subjects: 20
Study: 6741674

Group type: COMPARATOR
Intervention: Placebo beverage
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alcohol (two doses)
Number of subjects: 0
Study: 31742447

Group type: EXPERIMENTAL
Intervention: Fit Moms/Mamás Activas intervention (internet-based weight loss program)
Number of subjects: 0
Study: 30410987

Group type: EXPERIMENTAL
Intervention: Three-dimensional endoscopy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Two-dimensional endoscopy
Number of subjects: 0
Study: 27422656

Group type: EXPERIMENTAL
Intervention: Baseline health status assessment using EQ-5D-3L
Number of subjects: 539

Group type: EXPERIMENTAL
Intervention: Follow-up health status assessment 12 months later
Number of subjects: 539

Group type: EXPERIMENTAL
Intervention: Comparison of health utility scores over time
Number of subjects: 539

Group type: EXPERIMENTAL
Intervention: Age comparison of health utility scores
Number of subjects: 539
Study: 24519622

Group type: EXPERIMENTAL
Intervention: Knee flexed at 90° during surgical closing (Group 2)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Knee extended during surgical closing (Group 1)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Both groups received the same anaesthesia method, surgical team, surgical technique, prosthesis type, and rehabilitation process.
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Isokinetic evaluation at 180°/s
Number of subjects: 29
Study: 19694774

Group type: EXPERIMENTAL
Intervention: Parental-aid intervention (n = 114)
Number of subjects: 457

Group type: EXPERIMENTAL
Intervention: Combined intervention (n = 111)
Number of subjects: 457

Group type: COMPARATOR
Intervention: Class-work intervention (n = 115)
Number of subjects: 457

Group type: COMPARATOR
Intervention: Control group (n = 117)
Number of subjects: 457
Study: 15889510

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 65

Group type: COMPARATOR
Intervention: Medication (Control)
Number of subjects: 65
Study: 12352910

Group type: EXPERIMENTAL
Intervention: MMF for 3 months, replaced by AZA for 9 months (Group 1)
Number of subjects: 477

Group type: EXPERIMENTAL
Intervention: MMF for 12 months (Group 2)
Number of subjects: 477

Group type: COMPARATOR
Intervention: AZA for 12 months (Group 3)
Number of subjects: 477
Study: 9327829

Group type: EXPERIMENTAL
Intervention: Vascular injury treatment (angioplasty)
Number of subjects: 0
Study: 7695066

Group type: EXPERIMENTAL
Intervention: Oral immunotherapy (OIT) with birch pollen antigens in enterocoated capsules
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 30
Study: 3605563

Group type: EXPERIMENTAL
Intervention: 1.0 ml 25% cocaine HCl combined with 0.1% adrenaline in paraffin paste
Number of subjects: 20

Group type: COMPARATOR
Intervention: 1.0 ml 25% cocaine HCl in paraffin paste
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 4.0 ml aqueous 4% cocaine HCl combined with 0.05% adrenaline
Number of subjects: 20

Group type: COMPARATOR
Intervention: 4.0 ml aqueous 4% cocaine HCl on ribbon gauze
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cocaine adrenaline paste
Number of subjects: 20

Group type: COMPARATOR
Intervention: Plain cocaine paste
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Aqueous cocaine adrenaline
Number of subjects: 20

Group type: COMPARATOR
Intervention: Aqueous cocaine alone
Number of subjects: 20
Study: 31042441

Group type: EXPERIMENTAL
Intervention: Active bracing
Number of subjects: 16

Group type: COMPARATOR
Intervention: Passive placebo bracing
Number of subjects: 16

Group type: COMPARATOR
Intervention: Unbraced
Number of subjects: 16

Group type: COMPARATOR
Intervention: All tested conditions (active bracing, passive placebo bracing, unbraced)
Number of subjects: 16
Study: 29181582

Group type: EXPERIMENTAL
Intervention: ceVUS with Optison™
Number of subjects: 30

Group type: COMPARATOR
Intervention: VCUG
Number of subjects: 30
Study: 27130202

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide/albuterol (CVT-MDI)
Number of subjects: 226

Group type: COMPARATOR
Intervention: Albuterol (ALB-HFA)
Number of subjects: 226
Study: 24465438

Group type: EXPERIMENTAL
Intervention: B vitamins (0.56 mg 5‐methyl‐tetrahydrofolate, 3 mg vitamin B6, 0.02 mg vitamin B12)
Number of subjects: 2501

Group type: EXPERIMENTAL
Intervention: n‐3 fatty acids (600 mg eicosapentaenoic and docosahexaenoic acids in a 2:1 ratio)
Number of subjects: 2501

Group type: EXPERIMENTAL
Intervention: B vitamins and n‐3 fatty acids combined
Number of subjects: 2501

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2501
Study: 22142381

Group type: EXPERIMENTAL
Intervention: Continuous infraclavicular brachial plexus (CIBP) block
Number of subjects: 33

Group type: COMPARATOR
Intervention: Continuous stellate ganglion (CSG) block
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Both CIBP and CSG blocks
Number of subjects: 33
Study: 20664561

Group type: EXPERIMENTAL
Intervention: High protein diet (140 g/day)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Low protein diet (50 g/day)
Number of subjects: 17
Study: 17978064

Group type: EXPERIMENTAL
Intervention: Oral azithromycin, 500 mg/day for 28 days
Number of subjects: 45

Group type: COMPARATOR
Intervention: Intramuscular meglumine antimoniate, 10 mg Sb/kg/day for 28 days
Number of subjects: 45

Group type: COMPARATOR
Intervention: Intramuscular meglumine antimoniate (for patients who failed azithromycin)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Meglumine antimoniate
Number of subjects: 45
Study: 14762036

Group type: EXPERIMENTAL
Intervention: Warfarin (adjusted-dose, target INR 1.4-2.8)
Number of subjects: 1770

Group type: EXPERIMENTAL
Intervention: Aspirin (325 mg/d)
Number of subjects: 1770

Group type: EXPERIMENTAL
Intervention: Both LA and aCL antibodies positivity
Number of subjects: 1770
Study: 11477460

Group type: EXPERIMENTAL
Intervention: Lycopene (13.3 mg)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Beta-carotene (8.2 mg)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 10023273

Group type: EXPERIMENTAL
Intervention: Neuromuscular paralysis achieved with pancuronium (Group 2)
Number of subjects: 18

Group type: COMPARATOR
Intervention: No neuromuscular paralysis (Group 1)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Mechanical ventilation
Number of subjects: 18
Study: 7831627

Group type: EXPERIMENTAL
Intervention: Theophylline (oral, twice daily doses, trough serum concentrations between 8.4 and 13.5 mg/l)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Salbutamol (inhalation of 800 micrograms)
Number of subjects: 10
Study: 3241821

Group type: EXPERIMENTAL
Intervention: Aspirin 20 mg daily
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Aspirin 1000 mg daily
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 29660674

Group type: EXPERIMENTAL
Intervention: Borderline Personality Disorder (BPD) diagnosis
Number of subjects: 184

Group type: COMPARATOR
Intervention: No BPD diagnosis (Control)
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Comorbid BPD and Antisocial Personality Disorder (ASPD)
Number of subjects: 184

Group type: COMPARATOR
Intervention: ASPD diagnosis only (Control)
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: BPD diagnosis only
Number of subjects: 184
Study: 26888854

Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 200
Study: 26238480

Group type: EXPERIMENTAL
Intervention: Cryoballoon catheter ablation
Number of subjects: 41
Study: 24228447

Group type: EXPERIMENTAL
Intervention: 0.187% ropivacaine and fentanyl 3.2 microg x ml(‐1)
Number of subjects: 52

Group type: COMPARATOR
Intervention: 0.187% levobupivacaine and fentanyl 3.2 microg ml(‐1)
Number of subjects: 52
Study: 21185725

Group type: EXPERIMENTAL
Intervention: PSE music during loaded sit-to-stand (LSTS)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Continuation condition after PSE music
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control (no music)
Number of subjects: 23
Study: 18362823

Group type: EXPERIMENTAL
Intervention: Interview administration of FACT-G
Number of subjects: 1195

Group type: COMPARATOR
Intervention: Self-administration of FACT-G
Number of subjects: 1195
Study: 17194269

Group type: EXPERIMENTAL
Intervention: Risperidone (up to 6 mg/day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 14632294

Group type: EXPERIMENTAL
Intervention: Changing method based on protocol 1 for upper abdomen
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Changing method based on protocol 2 for chest
Number of subjects: 250

Group type: COMPARATOR
Intervention: Standard scanning with constant tube current for upper abdomen
Number of subjects: 250

Group type: COMPARATOR
Intervention: Standard scanning with constant tube current for chest
Number of subjects: 250
Study: 11558625

Group type: EXPERIMENTAL
Intervention: Intramuscular vitamin B12 (Tricortin 1000)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 9168442

Group type: EXPERIMENTAL
Intervention: Escalating doses of epirubicin
Number of subjects: 147

Group type: COMPARATOR
Intervention: Standard doses of epirubicin
Number of subjects: 147
Study: 8465839

Group type: EXPERIMENTAL
Intervention: Minoxidil
Number of subjects: 8

Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 8

Group type: COMPARATOR
Intervention: Nifedipine
Number of subjects: 8
Study: 2871092

Group type: EXPERIMENTAL
Intervention: Teicoplanin
Number of subjects: 198

Group type: COMPARATOR
Intervention: Flucloxacillin and Tobramycin
Number of subjects: 198
Study: 31630072

Group type: EXPERIMENTAL
Intervention: Direct in-person communication with family members
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Direct communication with a physician or nurse practitioner
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Informal bedside updates by nurses
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Phone calls to families
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: No communication contact
Number of subjects: 146
Study: 29320575

Group type: EXPERIMENTAL
Intervention: AZP-531 (3 mg for 50-70 kg and 4 mg for >70 kg body weight)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: AZP-531
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 27552643

Group type: EXPERIMENTAL
Intervention: Cornell voltage (CV-LVH)
Number of subjects: 3043

Group type: EXPERIMENTAL
Intervention: Cornell product (CP-LVH)
Number of subjects: 3043

Group type: COMPARATOR
Intervention: Sokolow-Lyon-LVH
Number of subjects: 3043

Group type: EXPERIMENTAL
Intervention: Cornell voltage and Cornell product criteria for LVH
Number of subjects: 3043

Group type: EXPERIMENTAL
Intervention: Cornell product
Number of subjects: 3043
Study: 25099397

Group type: EXPERIMENTAL
Intervention: Armodafinil 150 mg
Number of subjects: 433

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 433
Study: 23045301

Group type: EXPERIMENTAL
Intervention: iopromide
Number of subjects: 562

Group type: COMPARATOR
Intervention: iodixanol
Number of subjects: 562
Study: 19665142

Group type: EXPERIMENTAL
Intervention: DHEA (200 mg/d)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 18606587

Group type: EXPERIMENTAL
Intervention: Netilmicin once daily (5 mg/kg/die)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Netilmicin twice daily (5 mg/kg/die)
Number of subjects: 21
Study: 15681986

Group type: EXPERIMENTAL
Intervention: Relaxation breathing exercise (30 minutes daily for 6 weeks)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Relaxation breathing exercise
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 35
Study: 11996638

Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 0
Study: 10450626

Group type: EXPERIMENTAL
Intervention: Nicotine patch
Number of subjects: 632

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 632
Study: 7541051

Group type: EXPERIMENTAL
Intervention: TACE after radical resection
Number of subjects: 140

Group type: COMPARATOR
Intervention: Radical resection only
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: TACE after palliative hepatectomy
Number of subjects: 140

Group type: COMPARATOR
Intervention: Palliative resection only
Number of subjects: 140
Study: 1982330

Group type: EXPERIMENTAL
Intervention: Budesonide (800 micrograms) + procaterol
Number of subjects: 24

Group type: COMPARATOR
Intervention: Theophylline + procaterol
Number of subjects: 24
Study: 42425

Group type: EXPERIMENTAL
Intervention: Lorazepam 4 mg/70 kg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Morphine 10 mg
Number of subjects: 0
Study: 31888707

Group type: EXPERIMENTAL
Intervention: Internet-based Cognitive Behavioral Treatment (iCBT) added to treatment as usual (TAU)
Number of subjects: 260

Group type: COMPARATOR
Intervention: Treatment as usual (TAU) only
Number of subjects: 260
Study: 28291859

Group type: EXPERIMENTAL
Intervention: Two interforaminal Straumann implants (Regular Neck, 4.1 mm diameter, 8 mm length) loaded with Locator attachments transforming preexisting inferior conventional denture into an IOD.
Number of subjects: 19
Study: 26296857

Group type: EXPERIMENTAL
Intervention: Fish oil (4.4 g daily for 1 month)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 23459089

Group type: EXPERIMENTAL
Intervention: MOM trial Handbook plus structured physical activity and nutrition program
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard clinical care
Number of subjects: 60
Study: 21168841

Group type: EXPERIMENTAL
Intervention: SEDASYS System (SED)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Control standard care (CSC)
Number of subjects: 1000
Study: 19489491

Group type: EXPERIMENTAL
Intervention: Acupuncture and moxibustion on Guanyuan (CV 4), Qihai (CV 6), Zusanli (ST 36), Xuehai (SP 10), Geshu (BL 17)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Western medicine (Omeprazole and Amoxicillin)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Acupuncture and moxibustion
Number of subjects: 80
Study: 17196876

Group type: EXPERIMENTAL
Intervention: Influenza vaccination
Number of subjects: 100